Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS for ASO – New Data
Time: 4:30 pm
day: Day Two
Details:
- Presenting a novel drug delivery system for antisense oligonucleotides
- Achieving success in non-clinical experiments
- Showcasing early clinical results
